Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
Aim. Nature development of lymphoma associates with increased risk of cardiovascular diseases. We aimed to evaluate the prognostic value of circulating NT-proBNP, galectin-3, and VE-cadherin in survivors of Hodgkin lymphoma. Methods: Surveys were given to Hodgkin lymphoma survivors who reached at...
Saved in:
Main Author: | B. B. Samura |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2017-12-01
|
Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
Subjects: | |
Online Access: | http://pharmed.zsmu.edu.ua/article/view/113558/110369 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01) -
Elevation of Cardiac Biomarkers in COVID-19 As a Major Determinant for Mortality: A Systematic Review
by: Tracy Anabella Hermansyah, et al.
Published: (2022-01-01) -
The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure
by: Yanxiang Sun, et al.
Published: (2025-08-01) -
THE LEVEL OF CARDIAC PEPTIDE NT-PROBNP INCREASES DURING PRE-ECLAMPSIA OF PREGNANT WOMEN
by: Н. Русой, et al.
Published: (2025-04-01) -
Quality of life among patients after Hodgkin lymphoma treatment: a 3-year prospective study
by: B. B. Samura
Published: (2017-08-01)